OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Molecular Pathology of Ovarian Epithelial Neoplasms	25
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture	24
Forthcoming Issues	21
Digital Imaging and AI Pre-classification in Hematology	18
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	15
Molecular Detection of Oncogenic Gene Rearrangements	13
Current Topics in Molecular Diagnostics and Precision Medicine	13
Contributors	12
Point-of-Care Drug Testing	11
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	11
Copy Number Analysis in Cancer Diagnostic Testing	10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	10
Is It Possible to Test for Viral Infectiousness?	10
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine	10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	10
Molecular Oncology Diagnostics	10
Contributors	9
Contributors	9
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	9
Cell-free Nucleic Acids in Cancer	8
Flow Cytometry and Platelets	8
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory	8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	8
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management	8
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	8

Opportunities and Challenges with Artificial Intelligence in Genomics	8
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	7
Contents	7
Contents	7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	7
Artificial Intelligence for Clinical Flow Cytometry	7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	7
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	7
Copyright	6
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	6
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19	6
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	5
Electronic Health Record Optimization for Artificial Intelligence	5
Utility of Single-Gene Testing in Cancer Specimens	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness	5
Copyright	5
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	5
The Evolving Role of Molecular Diagnostics in Pathology	5
Steps Forward to a Fair and Inclusive Blood Supply	5
Molecular Biomarkers of Response to Cancer Immunotherapy	5
Point of Care Molecular Testing	5
Molecular Alterations in Pediatric Solid Tumors	5
Copyright	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation	4
Contents	4
Taking Center Stage	4
Rapid Antigen Assays for SARS-CoV-2	4
Diagnostic Stewardship for Multiplex Respiratory Testing	4
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2	4
Artificial Intelligence in the Clinical Laboratory	4
Contributors	4
Copyright	4
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	4
Transfusion Medicine Informatics	3
Transfusion Reactions and Adverse Events	3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	3
Childhood Myelodysplastic Syndrome	3
Promoting Gender Equality in Pathology and Laboratory Medicine Leadership	3
Molecular Methods	3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	3
Update on Ovarian Sex Cord–Stromal Tumors	3
A Winding Road to Health Care Equity in Sickle Cell Disease	3
Analytical Principles of Cancer Next Generation Sequencing	3
Contents	3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3
Contents	3
Molecular Pathology of Breast Tumors	3

Updates in Blood Banking and Transfusion Medicine	3
History, Advances, and Challenges of Sickle Cell Disease Treatment	3
Pathology Clinics Can Address Pathology Burnout	3
Copyright	3